ATE345115T1 - Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten - Google Patents
Zusammensetzungen zur behandlung von chlamydiale assozierten krankheitenInfo
- Publication number
- ATE345115T1 ATE345115T1 AT99928901T AT99928901T ATE345115T1 AT E345115 T1 ATE345115 T1 AT E345115T1 AT 99928901 T AT99928901 T AT 99928901T AT 99928901 T AT99928901 T AT 99928901T AT E345115 T1 ATE345115 T1 AT E345115T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- compositions
- chlamydial
- associated diseases
- trimoxazole
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 2
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 abstract 2
- 229930189077 Rifamycin Natural products 0.000 abstract 2
- 239000004098 Tetracycline Substances 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 239000004599 antimicrobial Substances 0.000 abstract 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 2
- 229960005091 chloramphenicol Drugs 0.000 abstract 2
- 229940047766 co-trimoxazole Drugs 0.000 abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 2
- 229940041033 macrolides Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 150000007660 quinolones Chemical class 0.000 abstract 2
- BTVYFIMKUHNOBZ-QXMMDKDBSA-N rifamycin s Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C(C)C(OC)\C=C/OC1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-QXMMDKDBSA-N 0.000 abstract 2
- 229940081192 rifamycins Drugs 0.000 abstract 2
- 229940124530 sulfonamide Drugs 0.000 abstract 2
- 150000003456 sulfonamides Chemical class 0.000 abstract 2
- 235000019364 tetracycline Nutrition 0.000 abstract 2
- 150000003522 tetracyclines Chemical class 0.000 abstract 2
- 229940040944 tetracyclines Drugs 0.000 abstract 2
- 241000606161 Chlamydia Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP4376A AUPP437698A0 (en) | 1998-06-30 | 1998-06-30 | Methods for treatment of coronary, carotid and other vascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE345115T1 true ATE345115T1 (de) | 2006-12-15 |
Family
ID=3808619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99928901T ATE345115T1 (de) | 1998-06-30 | 1999-06-30 | Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6475518B1 (de) |
| EP (2) | EP1754472B1 (de) |
| JP (3) | JP4651816B2 (de) |
| AT (1) | ATE345115T1 (de) |
| AU (2) | AUPP437698A0 (de) |
| CA (2) | CA2684402C (de) |
| DE (1) | DE69934010T2 (de) |
| ES (2) | ES2514469T3 (de) |
| NZ (1) | NZ509504A (de) |
| WO (1) | WO2000001378A1 (de) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6258532B1 (en) | 1997-08-14 | 2001-07-10 | Vanderbilt University | Methods for in vitro susceptibility testing of chlamydia |
| US6710033B1 (en) | 1996-08-14 | 2004-03-23 | Vanderbilt University | Methods and treatment of multiple sclerosis |
| US6890526B2 (en) | 1997-05-06 | 2005-05-10 | Vanderbilt University | Methods and reagents for the treatment of multiple sclerosis |
| US6756369B2 (en) * | 1997-05-06 | 2004-06-29 | Vanderbilt University | Diagnosis and management of infection caused by Chlamydia |
| AU3760400A (en) * | 1999-03-19 | 2000-10-09 | Vanderbilt University | Methods and reagents for the diagnosis and treatment of multiple sclerosis |
| US6991807B2 (en) * | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
| US6623757B2 (en) * | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Antibiotic composition |
| ES2312422T3 (es) * | 2000-03-22 | 2009-03-01 | PHARMACIA & UPJOHN COMPANY LLC | Formulacion de comprimido de oxazolidinona. |
| US6514529B2 (en) | 2000-03-22 | 2003-02-04 | Pharmacia & Upjohn Company | Oxazolidinone tablet formulation |
| IT1318459B1 (it) | 2000-04-11 | 2003-08-25 | Zambon Spa | Uso del tiamfenicolo e di suoi derivati per la preparazione dicomposizioni farmaceutiche utili per il trattamento di infezioni da |
| US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
| EP1262185A1 (de) * | 2001-05-30 | 2002-12-04 | New Pharma Research Sweden AB | Synergistische Antibiotika-enthaltende Zusammensetzungen |
| WO2003004098A1 (en) * | 2001-07-06 | 2003-01-16 | Sucampo Ag | Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
| AUPS017702A0 (en) * | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
| AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| CA2478121A1 (en) * | 2002-03-07 | 2003-09-18 | Advancis Pharmaceutical Corporation | Antibiotic composition |
| EP1531828A4 (de) * | 2002-05-23 | 2005-11-02 | Activbiotics Inc | Verfahren zur behandlung von bakterieninfektionen und damit zusammenhängenden erkrankungen |
| US20090149453A1 (en) * | 2002-05-23 | 2009-06-11 | Activbiotics Pharma Llc | Methods and compositions for treating bacterial infections and diseases associated therewith |
| US20040077533A1 (en) * | 2002-05-23 | 2004-04-22 | Sayada Chalom B. | Methods and compositions for treating bacterial infections and diseases associated therewith |
| US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
| EP1575567A4 (de) * | 2002-12-12 | 2008-10-08 | Activbiotics Inc | Verfahren und reagentien zur behandlungoder vorbeugung von arteriosklerose und damit einhergehenden krankheiten |
| US20040126414A1 (en) * | 2002-12-12 | 2004-07-01 | Michaelis Arthur F. | Methods and compositions for treating and preventing ear infections |
| US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| RU2254123C2 (ru) * | 2003-08-11 | 2005-06-20 | Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВСиДВ СО РАСХН) | Препарат для лечения гемобартонеллеза кошек и способ его применения |
| WO2005027961A2 (en) * | 2003-09-23 | 2005-03-31 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Chlamydia pmpd autotransporter and its role as adhesin |
| CA2555304C (en) | 2004-02-06 | 2016-06-28 | Nicolas Peter Shortis | Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome |
| US20080306029A1 (en) * | 2004-05-28 | 2008-12-11 | Salix Pharmaceuticals, Inc. | Prevention, Treatment, and Amelioration of Radiation Induced Enteritis |
| US20110097402A1 (en) * | 2004-09-30 | 2011-04-28 | Covalon Technologies Inc. | Non-adhesive elastic gelatin matrices |
| WO2006057429A1 (ja) * | 2004-11-24 | 2006-06-01 | Nanocarrier Co., Ltd. | ブロックコポリマーのモーフォロジ－の変化方法 |
| US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| WO2007025146A2 (en) * | 2005-08-24 | 2007-03-01 | Salix Pharmaceuticals, Inc. | Balsalazide formulations and manufacture and use thereof |
| US8921344B2 (en) * | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| FR2891744B1 (fr) * | 2005-10-06 | 2009-10-09 | France Etat Armement | Application a la chimioprophylaxie du paludisme d'une association de chloroquine et de doxycycline |
| WO2009015214A2 (en) * | 2007-07-24 | 2009-01-29 | Wayne State University | Nanoparticles for imaging and treating chlamydial infection |
| EP2365802B1 (de) | 2008-11-11 | 2017-08-02 | The Board of Regents,The University of Texas System | Mikrokapseln von rapamycin und deren verwendung zur behandlung von krebs |
| DE112010004110T8 (de) | 2009-10-22 | 2012-12-06 | Thomas Julius Borody | Neue parasitentherapie |
| US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
| EP2563117B1 (de) | 2010-04-26 | 2018-02-21 | Salix Pharmaceuticals, Ltd. | Formulierungen aus und verwendungen von 2-hydroxy-5-phenylazobenzoesäurederivaten zur behandlung männlicher patienten |
| CN103338768B (zh) | 2010-12-13 | 2019-04-19 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
| WO2013025105A1 (en) * | 2011-08-16 | 2013-02-21 | /Purac Biochem B.V. | Recovery of carboxylic acid from their magnesium salts by precipitation using hydrochloric acid, useful for fermentation broth work-up |
| HUE043852T2 (hu) | 2012-07-27 | 2019-09-30 | Redhill Biopharma Ltd | A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei |
| EP2968281B1 (de) | 2013-03-13 | 2020-08-05 | The Board of Regents of The University of Texas System | Mtor-hemmer zur vorbeugung von darmpolypenwachstum |
| AU2014373683B2 (en) | 2013-12-31 | 2020-05-07 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
| US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
| CA2997671A1 (en) * | 2015-10-06 | 2017-04-13 | Redhill Biopharma Ltd. | Combination therapies for treating cancer |
| US11197872B2 (en) | 2017-04-21 | 2021-12-14 | Lunella Biotech, Inc. | Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs) |
| CA3060509A1 (en) | 2017-04-21 | 2018-10-25 | Federica Sotgia | Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy |
| KR20200010343A (ko) | 2017-05-19 | 2020-01-30 | 루넬라 바이오테크 인코포레이티드 | 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제 |
| US12006553B2 (en) | 2017-05-19 | 2024-06-11 | Lunella Biotech, Inc. | Companion diagnostics for mitochondrial inhibitors |
| RU2020102908A (ru) | 2017-06-26 | 2021-07-27 | Лунелла Байотек, Инк. | Митокетосцины: митохондриальная терапия, нацеленная на кетоновый метаболизм в раковых клетках |
| WO2019148249A1 (en) * | 2018-02-01 | 2019-08-08 | Centre For Digestive Diseases | Compositions for treating infective arterial diseases and related conditions |
| RU2684728C1 (ru) * | 2018-05-21 | 2019-04-12 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Препарат на основе пчелиного маточного молочка для лечения мелких домашних животных при гемобартонеллезе |
| CN115867288A (zh) * | 2020-03-27 | 2023-03-28 | 维克多瑞有限公司 | 用于治疗呼吸系统病症的组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US588550A (en) | 1897-08-24 | Alarm-clock | ||
| GB1463550A (en) | 1974-08-06 | 1977-02-02 | Bodrero G | Pharmaceutical composition |
| GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
| FI883067A7 (fi) * | 1988-06-27 | 1989-12-28 | Labsystems Oy | Foerfarande foer behandling av koronarkaerlsjukdom. |
| US5914132A (en) | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| GB9416600D0 (en) | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
| US5624704A (en) | 1995-04-24 | 1997-04-29 | Baylor College Of Medicine | Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent |
| US6080757A (en) * | 1996-06-06 | 2000-06-27 | Pfizer Inc | Antibiotic quinolones and derivatives |
| US6838552B1 (en) * | 1997-08-14 | 2005-01-04 | Vanderbilt University | Diagnosis and management of infection caused by Chlamydia |
| US5811121A (en) | 1997-01-29 | 1998-09-22 | Eastman Chemical Company | PH-sensitive coatings based on cellulose acetoacetate |
| JP2002512622A (ja) * | 1997-05-06 | 2002-04-23 | バンダービルト ユニバーシティー | クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物 |
-
1998
- 1998-06-30 AU AUPP4376A patent/AUPP437698A0/en not_active Abandoned
-
1999
- 1999-06-20 US US09/736,029 patent/US6475518B1/en not_active Expired - Lifetime
- 1999-06-30 EP EP06023648.6A patent/EP1754472B1/de not_active Expired - Lifetime
- 1999-06-30 CA CA2684402A patent/CA2684402C/en not_active Expired - Lifetime
- 1999-06-30 ES ES06023648.6T patent/ES2514469T3/es not_active Expired - Lifetime
- 1999-06-30 AT AT99928901T patent/ATE345115T1/de not_active IP Right Cessation
- 1999-06-30 AU AU45919/99A patent/AU757293B2/en not_active Expired
- 1999-06-30 NZ NZ509504A patent/NZ509504A/en not_active IP Right Cessation
- 1999-06-30 CA CA2336593A patent/CA2336593C/en not_active Expired - Lifetime
- 1999-06-30 EP EP99928901A patent/EP1093363B1/de not_active Expired - Lifetime
- 1999-06-30 DE DE69934010T patent/DE69934010T2/de not_active Expired - Lifetime
- 1999-06-30 ES ES99928901T patent/ES2278449T3/es not_active Expired - Lifetime
- 1999-06-30 JP JP2000557825A patent/JP4651816B2/ja not_active Expired - Lifetime
- 1999-06-30 WO PCT/AU1999/000528 patent/WO2000001378A1/en not_active Ceased
-
2010
- 2010-03-29 JP JP2010074109A patent/JP5335726B2/ja not_active Expired - Lifetime
-
2013
- 2013-04-02 JP JP2013076511A patent/JP2013147504A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP4651816B2 (ja) | 2011-03-16 |
| JP2002519374A (ja) | 2002-07-02 |
| ES2514469T3 (es) | 2014-10-28 |
| JP2013147504A (ja) | 2013-08-01 |
| CA2684402C (en) | 2012-10-30 |
| AU4591999A (en) | 2000-01-24 |
| EP1754472A3 (de) | 2009-08-26 |
| EP1093363A4 (de) | 2003-09-24 |
| HK1037864A1 (en) | 2002-02-22 |
| JP5335726B2 (ja) | 2013-11-06 |
| AU757293B2 (en) | 2003-02-13 |
| CA2336593A1 (en) | 2000-01-13 |
| JP2010174030A (ja) | 2010-08-12 |
| CA2684402A1 (en) | 2000-01-13 |
| EP1093363A1 (de) | 2001-04-25 |
| AUPP437698A0 (en) | 1998-07-23 |
| EP1754472A2 (de) | 2007-02-21 |
| ES2278449T3 (es) | 2007-08-01 |
| CA2336593C (en) | 2010-06-29 |
| DE69934010T2 (de) | 2007-06-21 |
| EP1754472B1 (de) | 2014-07-23 |
| NZ509504A (en) | 2004-04-30 |
| EP1093363B1 (de) | 2006-11-15 |
| WO2000001378A1 (en) | 2000-01-13 |
| US6475518B1 (en) | 2002-11-05 |
| DE69934010D1 (de) | 2006-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE345115T1 (de) | Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten | |
| DE60117043D1 (de) | Behandlung von mukositis | |
| ATE232862T1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| ATE279942T1 (de) | Mehrwertige impstoffzusammensetzung mit gemischten trägern | |
| BR9913935A (pt) | Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| EP0932613A4 (de) | Expressionsblockierung von virulenten faktoren in s. aureus | |
| DE60041753D1 (de) | Arzneimittel zur behandlung von c. pneumoniae infektionen | |
| DE69825128D1 (de) | Verwendung von azithromycin zur topischen behandlung von augeninfektionen | |
| BR0111989A (pt) | Peptìdeos, composições e processos para o tratamento de burkholderia cepacia | |
| DE69631381D1 (de) | Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen | |
| PT775745E (pt) | Aptameros inibidores de catepsina g | |
| DK0824539T3 (da) | Dialkyltiacumicin-forbindelser | |
| DK1763339T3 (da) | Orale antimikrobielle farmaceutiske præparater | |
| ATE260097T1 (de) | Hopfensäuren zur hemmung von staphylococcus aureus | |
| DE60011601D1 (de) | Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen | |
| EP1496742A4 (de) | Verwendung von nichtantibakteriellen tetrazyklin-analoga und ihren formulierungen für die behandlung von bakteriellen exotoxinen | |
| DE69935662D1 (de) | Mittel zur prävention/behandlung entzündlicher darmerkrankungen | |
| BG101145A (bg) | Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа | |
| ATE196424T1 (de) | Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten | |
| ATE212229T1 (de) | Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden | |
| WO1998014567A3 (en) | Methods and compositions for inhibiting bacterial growth | |
| ATE298235T1 (de) | Heilmittel und prophylaxe von störungen der intestinalen schleimhäute | |
| DE69923117D1 (de) | Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |